I-Mab Reports Third Quarter 2024 Results - Morningstar

I-Mab Reports Third Quarter 2024 Results - Morningstar

2 weeks from now

1 day ago  · Third Quarter 2024 Financial Results. Cash Position. As of September 30, 2024, the Company had cash and cash equivalents, and short-term investments of $184.4 million, …

morningstar.com

I-Mab Reports Third Quarter 2024 Results

2 weeks from now

1 day ago  · Third Quarter 2024 Financial Results. Cash Position. As of September 30, 2024, the Company had cash and cash equivalents, and short-term investments of $184.4 million, …

i-mabbiopharma.com

I-Mab Reports Third Quarter 2024 Results - PR Newswire

2 weeks from now

1 day ago  · Third Quarter 2024 Financial Results. Cash Position. As of September 30, 2024, the Company had cash and cash equivalents, and short-term investments of $184.4 million, …

prnewswire.com

I-Mab Reports Third Quarter 2024 Results - Yahoo Finance

2 weeks from now

1 day ago  · Third Quarter 2024 Financial Results. Cash Position. As of September 30, 2024, the Company had cash and cash equivalents, and short-term investments of $184.4 million, …

yahoo.com

I Mab : Reports Third Quarter 2024 Results - MarketScreener

2 weeks from now

1 day ago  · Third Quarter 2024 Financial Results. Cash Position. As of September 30, 2024, the Company had cash and cash equivalents, and short-term investments of $184.4 million, …

marketscreener.com

I-Mab Reports Third Quarter 2024 Results | Citybiz

2 weeks from now

1 day ago  · Third Quarter 2024 Financial Results. Cash Position. As of September 30, 2024, the Company had cash and cash equivalents, and short-term investments of $184.4 million, …

citybiz.co

I-Mab Reports Third Quarter 2024 Results - BioSpace

2 weeks from now

20 hours ago  · Third Quarter 2024 Financial Results. Cash Position. As of September 30, 2024, the Company had cash and cash equivalents, and short-term investments of $184.4 million, …

biospace.com

I-Mab Reports 1H 2024 Financial Results, Pipeline ... - Morningstar

2 weeks from now

Aug 28, 2024  · First-Half 2024 Financial Results. Cash Position. As of June 30, 2024, the Company had cash and cash equivalents, and short-term investments of $207.5 million, …

morningstar.com

I Mab : Reports Third Quarter 2024 Results Form 6 K

2 weeks from now

1 day ago  · Third Quarter 2024 Financial Results. Cash Position. As of September 30, 2024, the Company had cash and cash equivalents, and short-term investments of $184.4 million, …

marketscreener.com

I-Mab Reports Third Quarter 2024 Results - Nasdaq

2 weeks from now

Sep 30, 2024  · Third Quarter 2024 Financial Results Cash Position As of September 30, 2024 , the Company had cash and cash equivalents, and short-term investments of $184.4 million , …

nasdaq.com

Morningstar, Inc. Reports Third-Quarter 2024 Financial Results

2 weeks from now

Oct 23, 2024  · Third-Quarter 2024 Results Revenue increased 10.5% to $569.4 million on a reported basis and 10.1% on an organic basis versus the prior-year period, driven by strength …

morningstar.com

Invivyd Reports Third Quarter 2024 Financial Results And ... - Nasdaq

2 weeks from now

1 day ago  · Third Quarter 2024 Financial Results Revenue: Reported $9.3 million of net product revenue of PEMGARDA in Q3 2024 as compared to $2.3 million in Q2 2024. Cash Position: …

nasdaq.com

Alector Reports Third Quarter 2024 Financial Results And

2 weeks from now

Nov 6, 2024  · For the quarter ended September 30, 2024, Alector reported a net loss of $42.2 million, or $0.43 per share, compared to a net loss of $44.5 million, or $0.53 per share, for the …

morningstar.com

ENDRA Life Sciences Reports Third Quarter 2024 Financial Results …

2 weeks from now

20 hours ago  · Third Quarter 2024 Financial Results. Operating expenses in the third quarter of 2024 were down 52% to $1.5 million compared with $3.1 million in the third quarter in 2023, …

morningstar.com

IAnthus Reports Third Quarter 2024 Financial Results - Morningstar

2 weeks from now

3 days ago  · Third Quarter 2024 Financial Highlights. Revenue of $40.3 million, a sequential decrease of 6.3% from Q2 2024 and a decrease of 6.1% from the same quarter in the prior …

morningstar.com

Interactive Strength Inc. (Nasdaq:TRNR) Reports Third Quarter …

2 weeks from now

1 day ago  · The Company achieved third quarter revenue guidance of $2.0 million, a growth of 325% versus second quarter of 2024. The Company expects to generate $2.4 million in …

morningstar.com

Avalo Reports Third Quarter 2024 Financial Results And

2 weeks from now

Nov 7, 2024  · The Company’s current cash on hand is expected to fund operations into at least 2027. Research and development expenses were $9.5 million for the third quarter of 2024, an …

morningstar.com

Elevation Oncology Reports Third Quarter 2024 Financial Results …

2 weeks from now

Nov 6, 2024  · Third Quarter 2024 Financial Results As of September 30, 2024 , Elevation Oncology had cash, cash equivalents and marketable securities totaling $103.1 million , …

morningstar.com